Snapshot from May 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Sana Biotechnology

Tracked across 7 events · 64 articles · First seen Mar 26, 2025 · Last active May 28, 2026

Sentiment
-24
Attention
8
Events
7
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 -70
Business
Impact: Sana Biotechnology is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding its financial capacity and product candidates, leading to significant stock price drops.
Mar 27, 2025 · 6 articles
3 -50
Business
Impact: Sana Biotechnology is the defendant in a class action lawsuit, accused of making false and misleading statements regarding its financial capacity and product candidates, which could lead to significant financial and reputational damage.
Mar 26, 2025 · 6 articles
4 -70
Business
Impact: Sana Biotechnology is the defendant in a class action securities lawsuit, facing allegations of making false and misleading statements regarding its financial capacity and product candidates, which could lead to significant financial losses and reputational damage.
Mar 27, 2025 · 20 articles
3 -70
Business
Impact: Sana Biotechnology is facing a class action lawsuit for allegedly issuing materially false and/or misleading statements regarding its financial capacity and product candidates, leading to artificial inflation of its stock.
Mar 26, 2025 · 7 articles
4 70
Business
Impact: Sana Biotechnology entered a strategic collaboration with Mayo Clinic to advance the development of SC451, its investigational cell therapy for type 1 diabetes. This collaboration is expected to accelerate the clinical development and potential market adoption of SC451, positively impacting Sana Biotechnology's stock price and future prospects.
Apr 13, 2026 · 6 articles
4 20
Business
Sana Biotechnology announced the sale of 21,607,878 shares of its common stock through an at-the-market (ATM) facility established with Toronto-Dominion Bank — TD Securities, generating approximately $69 million in net proceeds. This investment, which included…
Impact: Sana Biotechnology sold 21,607,878 shares of its common stock through an ATM facility, raising approximately $69 million, which extends its cash runway to mid-2027. This capital raise is positive for the company's financial stability and ongoing operations.
May 15, 2026 · 6 articles
8 0
Business
Impact: Sana Biotechnology jointly developed UBT251 with Novo Nordisk, a triple agonist drug that showed significant weight loss in trials.
Feb 24, 2026 · 13 articles
NEWSDESK
Track Sana Biotechnology live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.